A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome

Inclusion Criteria: * Participants with aqueous tear deficiency * Literate, able to speak English or Spanish, and able to complete questionnaires independently * Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol Exclusion Criteria: * Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in the opinion of the investigator, may lead to clinically significant increased bleeding * Nasal or sinus surgery including nasal cautery or significant trauma * Cardiac demand pacemaker, implanted defibrillator or other implanted electronic device * Diagnosis of epilepsy * Corneal transplant in either or both eyes * Participation in any clinical trial with a new active substance or a new device within 30 days of the Screening Visit * A woman who is pregnant, planning a pregnancy, or nursing at the Screening Visit